UCLA Santa Monica Hematology/Oncology

Santa Monica, California 90404

2 studies enrolling now · 9 studies all time

What they study most

Advanced Cancer, Carcinoma, Hepatocellular, Colorectal Cancer, Diffuse Large B-cell Lymphoma, Early Breast Cancer, Lymphoma, Non-Hodgkin, Neoplasms, Non-Small-Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Solid Tumor, Solid Tumors

Studies at this site

• A Study of ASP3082 in Adults With Advanced Solid Tumors — Recruiting now
• A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors — Recruiting now
• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling
• Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7 — Stopped early
• Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies — Stopped early
• A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors — Completed
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early
• Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors — Completed
• Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer — Stopped early